Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of L-dopa in schizophrenia.

× No keyword cloud information.

7 in total

1. A review of patient outcomes in pharmacological studies from the psychiatric literature, 1966-1993.

Authors: Adil E Shamoo; Dianne N Irving; Patricia Langenberg
Journal: Sci Eng Ethics Date: 1997-10 Impact factor: 3.525

Review 2. Negative symptoms: psychopathological models.

Authors: J Ananth; A Djenderdjian; P Shamasunder; J Costa; J Herrera; J Sramek
Journal: J Psychiatry Neurosci Date: 1991-03 Impact factor: 6.186

3. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.

Authors: R J Hardie; A J Lees
Journal: J Neurol Neurosurg Psychiatry Date: 1988-06 Impact factor: 10.154

Review 4. A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications.

Authors: George E Jaskiw; Anand P Popli
Journal: Psychopharmacology (Berl) Date: 2003-12-11 Impact factor: 4.530

5. Partial improvement in negative schizophrenic symptoms after amphetamine.

Authors: B Angrist; E Peselow; M Rubinstein; J Corwin; J Rotrosen
Journal: Psychopharmacology (Berl) Date: 1982 Impact factor: 4.530

Review 6. Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia.

Authors: H J Möller; H M van Praag; B Aufdembrinke; P Bailey; T R Barnes; J Beck; H Bentsen; F X Eich; L Farrow; W W Fleischhacker
Journal: Psychopharmacology (Berl) Date: 1994-06 Impact factor: 4.530

Review 7. Discovery research and development history of the dopamine D₂ receptor partial agonists, aripiprazole and brexpiprazole.

Authors: Tetsuro Kikuchi; Kenji Maeda; Mikio Suzuki; Tsuyoshi Hirose; Takashi Futamura; Robert D McQuade
Journal: Neuropsychopharmacol Rep Date: 2021-05-07